Baek Se Jin, Kim Chang Woo, Cho Min Soo, Jang Hyun A, Baik Seung Hyuk, Hur Hyuk, Min Byung Soh, Kim Nam Kyu
Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea.
Dis Colon Rectum. 2015 Jun;58(6):575-81. doi: 10.1097/DCR.0000000000000373.
Few studies have examined the surgical treatment of intestinal Behçet disease. Consequently, there is currently no standard surgical treatment for intestinal Behçet disease. Instead, treatment is empirical and symptom based.
Our aim was to evaluate the clinical course after surgery and determine the appropriate surgical options for intestinal Behçet disease.
Medical charts of patients who underwent surgery for intestinal Behçet were retrospectively reviewed.
The study was conducted at a tertiary referral center.
Ninety-one patients who underwent surgical treatment for intestinal Behçet disease between January 1995 and December 2012 were included in this study.
Primary outcomes measured were patient demographics, clinical characteristics, operative and postoperative outcomes, and long-term follow-up data.
Surgical treatment was mainly in response to intractability to medical treatment (56.0%), and 19.8% of patients underwent an emergency operation. Surgery was performed laparoscopically in 33.0% of the patients. Most patients received an ileocecectomy (39.6%) or a right hemicolectomy (34.1%). Twenty-eight patients (30.8%) experienced postoperative morbidities, and 8 patients (8.8%) required reoperations. There were 3 deaths. Reoperation was required for recurrent disease in 32 patients during the long-term follow-up, and the 5-year cumulative reoperation rate was 31.2% (95% CI, 20.4%-42.0%). Among those requiring a second operation, 53.1% were segmental colonic resections that included the previous anastomosis. From multivariable Cox regression analysis, independent predictors of surgical recurrence included postoperative use of steroids (HR = 2.85 (95% CI, 1.21-6.75); p = 0.02), postoperative complications (HR = 2.42 (95% CI, 1.12-5.22); p = 0.03), and BMI (HR per 1-kg/m increase in BMI = 0.90 (95% CI, 0.82-0.99); p = 0.04).
This study was designed retrospectively and had a small sample size.
Patients treated surgically for intestinal Behçet disease frequently have postoperative complications and the need for a stoma and have a high risk of recurrence.
很少有研究探讨肠道白塞病的手术治疗。因此,目前肠道白塞病尚无标准的手术治疗方法。相反,治疗是经验性的且基于症状。
我们的目的是评估手术后的临床病程,并确定肠道白塞病合适的手术选择。
对接受肠道白塞病手术患者的病历进行回顾性分析。
该研究在一家三级转诊中心进行。
本研究纳入了1995年1月至2012年12月期间接受肠道白塞病手术治疗的91例患者。
测量的主要结局包括患者人口统计学特征、临床特征、手术及术后结局以及长期随访数据。
手术治疗主要是针对药物治疗无效(56.0%),19.8%的患者接受了急诊手术。33.0%的患者采用腹腔镜手术。大多数患者接受了回盲部切除术(39.6%)或右半结肠切除术(34.1%)。28例患者(30.8%)出现术后并发症,8例患者(8.8%)需要再次手术。有3例死亡。在长期随访中,32例患者因疾病复发需要再次手术,5年累积再次手术率为31.2%(95%CI,20.4%-42.0%)。在需要二次手术的患者中,53.1%是包括先前吻合口的节段性结肠切除术。多变量Cox回归分析显示,手术复发的独立预测因素包括术后使用类固醇(HR = 2.85(95%CI,1.21-6.75);p = 0.02)、术后并发症(HR = 2.42(95%CI,1.12-5.22);p = 0.03)和BMI(BMI每增加1kg/m²,HR = 0.90(95%CI,0.82-0.99);p = 0.04)。
本研究为回顾性设计,样本量较小。
接受手术治疗的肠道白塞病患者术后常出现并发症,需要造口,且复发风险高。